Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| ALXO | NASDAQ | ALX Oncology Holdings Inc. | $1.94 | +2.11% | 1M | $261.05M |
| FHTX | NASDAQ | Foghorn Therapeutics Inc. | $4.42 | -1.56% | 289K | $259.52M |
| GALT | NASDAQ | Galectin Therapeutics Inc. | $3.91 | +0.26% | 244K | $257.5M |
| AKBA | NASDAQ | Akebia Therapeutics, Inc. | $0.95 | +0.55% | 6.1M | $255.3M |
| MGNX | NASDAQ | MacroGenics, Inc. | $4.00 | +0.76% | 382K | $254.25M |
| ZNTL | NASDAQ | Zentalis Pharmaceuticals, Inc. | $3.51 | -2.23% | 788K | $249.86M |
| RXST | NASDAQ | RxSight, Inc. | $6.02 | +1.01% | 451K | $249.21M |
| RCEL | NASDAQ | Avita Medical Inc. | $9.88 | +0.20% | 225K | $245.45M |
| AVXL | NASDAQ | Anavex Life Sciences Corp. | $2.62 | -1.50% | 624K | $242.8M |
| NAGE | NASDAQ | Niagen Bioscience Inc | $3.04 | +0.16% | 321K | $242.12M |
| RNAC | NASDAQ | Cartesian Therapeutics, Inc. | $8.19 | -2.85% | 123K | $240.63M |
| ALEC | NASDAQ | Alector, Inc. | $2.14 | -0.70% | 4.7M | $237.59M |
| WHWK | NASDAQ | Whitehawk Therapeutics Inc | $4.11 | +0.98% | 284K | $234.31M |
| CGEN | NASDAQ | Compugen Ltd. | $2.47 | +0.41% | 162K | $233.55M |
| VRXA | NASDAQ | Veraxa Biotech Holding AG | $1.65 | +1.21% | 89K | $233.32M |
| ACB | NASDAQ | Aurora Cannabis Inc. | $3.74 | +0.27% | 811K | $231.66M |
| IVVD | NASDAQ | Invivyd, Inc. | $0.79 | +1.24% | 4.4M | $231.41M |
| CRDL | NASDAQ | Cardiol Therapeutics Inc. | $2.00 | +0.76% | 1.2M | $229.97M |
| GLSI | NASDAQ | Greenwich LifeSciences, Inc. | $15.45 | +2.59% | 75K | $226.78M |
| OSUR | NASDAQ | OraSure Technologies, Inc. | $3.25 | +0.62% | 467K | $223.76M |
| SPOK | NASDAQ | Spok Holdings, Inc. | $10.65 | +0.19% | 86K | $222.45M |
| HITI | NASDAQ | High Tide Inc. | $2.53 | -1.17% | 592K | $222.31M |
| UTMD | NASDAQ | Utah Medical Products, Inc. | $69.71 | +0.10% | 18K | $221.96M |
| BDSX | NASDAQ | Biodesix, Inc. | $26.97 | +3.55% | 46K | $219.5M |
| SIGA | NASDAQ | SIGA Technologies, Inc. | $3.03 | +0.33% | 453K | $217.32M |
| PROF | NASDAQ | Profound Medical Corp. | $5.97 | +0.17% | 362K | $216.94M |
| SLGL | NASDAQ | Sol-Gel Technologies Ltd. | $65.94 | -1.27% | 24K | $215.56M |
| TARA | NASDAQ | Protara Therapeutics, Inc. | $3.82 | +0.79% | 532K | $214.7M |
| ELDN | NASDAQ | Eledon Pharmaceuticals, Inc. | $2.78 | -0.36% | 633K | $214.58M |
| ABOS | NASDAQ | Acumen Pharmaceuticals, Inc. | $2.92 | +2.10% | 318K | $210.9M |
| STIM | NASDAQ | Neuronetics, Inc. | $3.03 | +0.66% | 749K | $210.85M |
| IVA | NASDAQ | Inventiva S.A. | $4.02 | -2.90% | 1.7M | $208.97M |
| NKTX | NASDAQ | Nkarta, Inc. | $2.91 | +3.56% | 487K | $208.2M |
| PEPG | NASDAQ | PepGen Inc. | $2.98 | -1.32% | 682K | $206.12M |
| CHRS | NASDAQ | Coherus Oncology, Inc. | $1.33 | -0.75% | 529K | $205.49M |
| PYXS | NASDAQ | Pyxis Oncology, Inc. | $3.21 | -1.83% | 1.1M | $203.37M |
| PDEX | NASDAQ | Pro-Dex, Inc. | $62.81 | +4.95% | 63K | $200.52M |
| DERM | NASDAQ | Journey Medical Corporation | $7.23 | +1.97% | 168K | $198.98M |
| PRQR | NASDAQ | ProQR Therapeutics N.V. | $1.86 | -4.12% | 579K | $195.87M |
| ANTX | NASDAQ | AN2 Therapeutics, Inc. | $5.41 | -4.92% | 104K | $194.85M |
| NERV | NASDAQ | Minerva Neurosciences, Inc. | $4.15 | -0.24% | 136K | $193.34M |
| VYGR | NASDAQ | Voyager Therapeutics, Inc. | $3.19 | -0.37% | 276K | $192.74M |
| NMRA | NASDAQ | Neumora Therapeutics, Inc. Common Stock | $1.04 | -8.77% | 1.9M | $192.7M |
| ORGO | NASDAQ | Organogenesis Holdings Inc. | $1.49 | -2.61% | 844K | $191.73M |
| ORMP | NASDAQ | Oramed Pharmaceuticals Inc. | $4.66 | -2.10% | 144K | $190.72M |
| TNXP | NASDAQ | Tonix Pharmaceuticals Holding Corp. | $11.87 | -3.34% | 512K | $189.22M |
| NBP | NASDAQ | NovaBridge Biosciences | $1.59 | -5.92% | 253K | $183.27M |
| NGEN | NASDAQ | NervGen Pharma Corp. Common stock | $2.19 | +1.16% | 559K | $179.59M |
| RNA | NASDAQ | Atrium Therapeutics, Inc. | $10.36 | +0.10% | 247K | $177.21M |
| IPHA | NASDAQ | Innate Pharma S.A. | $1.87 | -0.53% | 8K | $175.6M |
50 Healthcare Companies
Review companies currently returned for the Healthcare screen, with price, performance, volume and market-cap context.
How This Sector Screen Works
Results are loaded from current company data and can be narrowed by exchange or company search without changing the canonical sector page.
About the Healthcare Sector
The Healthcare classification groups companies with related business activities so investors can compare peers within a common market segment.
Related Sector Screens
Return to the screener directory to compare this sector with daily movers and the other industry groups covered by Cashu Finance.